Sewage can detect surges and variants before testing, CDC says. By BETH MOLE The Centers for Disease Control and Prevention on Friday announced it is now publicly logging levels of SARS-CoV-2 found in sewage from around the country. The announcement elevates a...
Among those under age 50, vaccination even without a booster protected strongly against hospitalization and death, according to new C.D.C. data. By Apoorva Mandavilli The Centers for Disease Control and Prevention on Thursday night published new data on the risks of...
By Michael Bang Petersen Dr. Petersen is a professor of political science at Aarhus University. He advises the Danish government on Covid policy and runs a study of Covid behaviors and attitudes in Denmark, six other European countries and the United States. For...
Hamsters are only the second species known to have spread SARS-CoV-2 to humans. By Smriti Mallapaty Pet hamsters probably carried the Delta variant of SARS-CoV-2 into Hong Kong and sparked a human COVID-19 outbreak, according to a genomic analysis of viral samples...
By Jonas Herby, Lars Jonung, and Steve H. Hanke From the January 2022 issue of Studies in Applied Economics from Johns Hopkins Institute for Applied Economics, Global Health, and the Study of Business Enterprise About the SeriesThe Studies in Applied Economics series...
— "We wouldn't say yes on the promise that three doses [will be] of value" by Kristina Fiore The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) is facing a very difficult decision. Members are being asked to consider whether a three-dose...
By Chris Kresser, from his newletter Is this a good idea? Under the FDA guidelines, a product must meet the following four criteria to obtain an EUA: There must be an emergency.A vaccine must be at least 30% to 50% effective.The known and potential benefits of the...
Immunologists have raced to work out how to protect against multiple variants of SARS-CoV-2. Their research has yielded a wealth of insights and a few surprises. By Cassandra Willyard No one anticipated how quickly Omicron would sweep the globe. Although the surge...
The risk of death for patients with SARS–CoV-2 infection and thoracic cancer is based on seven major determinants, according to research published by Alessio Cortellini, MD, in the Journal of Thoracic Oncology. Alessio Cortellini, MD TERAVOLT Data The...
Nasal vaccines under development around the world may make better boosters by stopping the coronavirus in the airways. By Apoorva Mandavilli On the outskirts of this centuries-old Indian city, a world away from its congested roads and cacophony, the gleaming modern...
Trial in which volunteers were given dose of virus is first to monitor people during entire course of infection By Hannah Devlin Exposure to a single nasal droplet is sufficient to become infected with Covid-19, according to a landmark trial in which healthy...
Cancer-killing cells still present 10 years on, with results suggesting therapy is a cure for certain blood cancers By Linda Geddes Two of the first human patients to be treated with a revolutionary therapy that engineers immune cells to target specific types of...
Only half of participants who were exposed to the coronavirus developed infections, most with mild symptoms. By Ewen Callaway Healthy, young people who were intentionally exposed to the coronavirus SARS-CoV-2 developed mild symptoms — if any — in a first-of-its-kind...
I am an English medical doctor and professor of epidemiology. I became known in media across the world as one of the first people who told their stories of long covid. I went on a roller coaster of symptoms and uncertainty for several months until I learnt some...
By Rick Bright Dr. Bright is an immunologist, virologist and a vaccine expert. He’s the chief executive of the Pandemic Prevention Institute, and he directed the federal government’s Biomedical Advanced Research and Development Authority from 2016 to 2020. When...